US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 15.160
  • +0.290+1.95%
Close Jan 17 16:00 ET
  • 15.160
  • 0.0000.00%
Post 16:33 ET
2.00BMarket Cap-9.97P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Centessa Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Centessa Pharmaceuticals Earnings Reports

  • Centessa Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 09:31 ET

  • Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

    Nov 12, 2024 09:30 ET

  • Centessa Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Oct 18, 2024 16:04 ET

  • Centessa Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 07:32 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 18, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data